Outpatient treatment of children and adolescents with antidepressants in Croatia

References

• Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 2002;41:514–21.
   PubMed Web of Science ®Google Scholar
• Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 2001; 155: 560–5.
   PubMed Web of Science ®Google Scholar
• Zito JM, Safer DJ, Reis S, Gardner JF, Magder L, Soeken K, . Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003; 157: 17–25.
   PubMed Web of Science ®Google Scholar
• Shatin D, Drinkard CR. Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Ambul Pediatr 2002; 2: 111–19
   PubMedGoogle Scholar
• Emslie GJ, Rush AJ, Weinberg WA. A double-blind, randomized, placebocontrolled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54: 1031–7.
   PubMed Web of Science ®Google Scholar
• The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New Engl J Med 2001; 344: 1279–85.
   PubMed Web of Science ®Google Scholar
• Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 2001; 158:2008–14.
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, . Fluoxetine for acute treatment of depression in children and adolescents: a placebo controlled randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41: 1205–15.
   PubMed Web of Science ®Google Scholar
• March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, . Fluoxetine, cognitive-behavioural therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. J Am Med Assoc 2004; 292: 807–20.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004; 161: 1079–83.
   PubMed Web of Science ®Google Scholar
• Wagner KD, Ambrosini PJ, Rynn M, Wohlberg C, Yang R, Greenbaum MS, . Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. J Am Med Assoc 2003; 290: 1033–41.
   PubMed Web of Science ®Google Scholar
• Rynn MA, Riddle MA, Yeung PP, Kunz NR. Efficacy and safety of extended release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry 2007; 164: 290–300.
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, . Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. J Am Med Assoc 2007; 297: 1683–96.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA approves Prozac for pediatric use to treat depression and OCD. FDA talk paper TO3-01. www.fda.gov/bbs/topics/ANSWERS/2003/ANS01187.html. Published 2003 [accessed 3 January 2011].
   Google Scholar
• United Kingdom Committee on Safety of Medicines Medicines and Healthcare Products Regulatory Agency. Use of selective serotonin reuptake inhibitors (SSRIs) in children and adolescents with major depressive disorder (MDD). http://www.focusproject.org.uk/pooled/articles/BF_NEWSART/view.asp?Q=BF_NEWSART_83376 Published 2003 [accessed 3 January 2011].
   Google Scholar
• Hammad T, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332–9.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. European Medicines Agency finalises review of antidepressants in children and adolescents. http://www.legemiddleverket.no/upload/15421/EMAE-press25april2005.pdf. Published April 25, 2005 [accessed 30 January 2011].
   Google Scholar
• Murray ML, De Vries CS, Wong ICK. A drug utilisation study of antidepressants in children and adolescents using the general practice research database. Arch Dis Child 2004;89:1098–102.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, . Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007;64:466–72.
   PubMed Web of Science ®Google Scholar
• Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007;164:884–91.
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, . Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;164:1356–63.
   PubMed Web of Science ®Google Scholar
• Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Can Med Assoc J 2008;178:1005–11.
   PubMed Web of Science ®Google Scholar
• Clavenna A, Rossi E, DeRosa M, Bonati M. Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr 2007;166:339–47.
   PubMed Web of Science ®Google Scholar
• Zoëga H, Baldursson G, Hrafnkelsson B, Almarsdóttir AB, Valdimarsdóttir U, Halldórsson M. Psychotropic drug use among Icelandic children: A nationwide population-based study. J Child Adolesc Psychopharmacol 2009;19: 757–64.
   PubMed Web of Science ®Google Scholar
• Foulon V, Svala A, Koskinen H, Chen TF, Saastamoinen LK, Bell JS. Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland. J Child Adolesc Psychopharmacol 2010;20:145–50.
   PubMed Web of Science ®Google Scholar
• Fegert JM, Kölch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 2006;16:197–206.
   PubMed Web of Science ®Google Scholar
• Croatian Bureau of Statistics. Statistical Information 2010. www.dzs.hr/Hrv_Eng/StatInfo/pdf/StatInfo2010.pdf Published 2010 [assessed 5 May 2011].
   Google Scholar
• Sevilla-Dedieu C, Kovess-Masfety V. Psychotropic medication use in children and adolescents: A study from France. J Child Adolesc Psychopharmacol 2008; 18: 281–9.
   PubMed Web of Science ®Google Scholar
• Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among U.S. children, 1997–2002. J Am Acad Child Adolesc Psychiatry 2006; 45: 271–9.
   PubMed Web of Science ®Google Scholar
• Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003; 60: 837–44.
   PubMed Web of Science ®Google Scholar
• Zalsman G, Brent DA, Weersing VR. Depressive disorders in childhood and adolescence: an overview epidemiology, clinical manifestation and risk factors. Child Adolesc Psychiatric Clin N Am 2006; 15: 827–41.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci 2009; 11: 7–20.
   PubMedGoogle Scholar
• Shireman TI, Olson BM, Dewan NA. Patterns of antidepressant use among children and adolescents. Psychiatr Serv 2002; 53: 1444–50.
   PubMed Web of Science ®Google Scholar
• Graovac M. The therapeutic effects of tianeptin on adolescents. Eur Psychiatry 2009; 24(Suppl 1): S646.
   Google Scholar
• Compton SN, Grant PJ, Chrisman AK, Gammon PJ, Brown VL, March JS. Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 564–71.
   PubMed Web of Science ®Google Scholar
• Ufer M, Rane A, Karlsson A, Kimland E, Bergman U. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Eur J Clin Pharmacol 2003; 58: 779–83.
   PubMed Web of Science ®Google Scholar
• Volkers AC, Heerdink ER, van Dijk L. Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001–2005). Pharmacoepidemiol Drug Saf 2007; 16: 1054–62.
   PubMed Web of Science ®Google Scholar
• Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L. Multiple Psychotropic Pharmacotherapy Among Child and Adolescent Enrollees in Connecticut Medicaid Managed Care. Psychiatr Serv 2003; 54: 72–7.
   PubMed Web of Science ®Google Scholar
• American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46: 267–83.
   PubMed Web of Science ®Google Scholar
• Woolstron JL. Combined pharmacotherapy: pitfalls of treatment. J Am Acad Child Adolesc Psychiatry 1999; 38: 1455–7.
   PubMed Web of Science ®Google Scholar